The pharmaceutical giant is challenging a provision in the Inflation Reduction Act that would let Medicare negotiate drug prices.
Eliquis maker Bristol Myers Squibb sues over Medicare plan to cut drug costs
The pharmaceutical giant is challenging a provision in the Inflation Reduction Act that would let Medicare negotiate drug prices.